肺癌放化疗“实时”疗效评估方法的研究进展
被引量:6
Research progress of evaluating methods in real-time curative effect for radiochemotherapy in lung cancer
摘要
肺癌是世界范围内最常见的恶性肿瘤,保守估计,2012年美国的新发肿瘤中,肺癌位居第二,死亡率居首位¨引。目前肺癌总体生存率却仅有16%左右。随着“个体化”这一治疗理念的提出,根据每一个肺癌患者的肿瘤生物学特征及药物基因组学改变进行针对性治疗,是目前肺癌规范化治疗的准则。但由于肺癌的异质性,其耐药、复发和转移成为目前面临的难题。“生存期”是临床评价疗效好坏的金标准,而在处理个体患者时并不适用。对个体患者而言,只有当生存期的延长与“缓解率”和生活质量的提高相关联时才具有价值。而以CT、MRI等影像学技术为基础评估“缓解率”的方法,
出处
《中华肺部疾病杂志(电子版)》
CAS
2013年第4期60-63,共4页
Chinese Journal of Lung Diseases(Electronic Edition)
参考文献26
-
1钱桂生.为提高我国呼吸系统疾病的诊治水平而努力[J].中华肺部疾病杂志(电子版),2012,5(1):1-3. 被引量:54
-
2Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012[ J]. CA Cancer J Clin, 2012, 62(1) :10-29. 被引量:1
-
3Hallqvist A, Bergman B, Nyman J. Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab-pooled results from two prospective clinical trials [ J ]. Radiother Oncol, 2012, 104 ( 1 ) :3944. 被引量:1
-
4Ganguli A, Wiegand P, Gao X, et al. The impact of second-line agents on patients' health-related quality of life in the treatment for non-small cell lung cancer: a systematic review [ J]. Qual Life Res, 2013, 22(5) : 1015-1026. 被引量:1
-
5石远凯,李峻岭,吴昌归,等.亚太地区含泰索帝方案一线治疗晚期非小细胞肺癌(NSCLC)患者生活质量(QOL)评估及与缓解率相关性的多中心Ⅲ期临床研究:中国患者亚组中期总结[C].第三届中国肿瘤内科大会教育集暨论文集.北京.中国协和医科大学出版社,2009.478-480. 被引量:1
-
6Saad ED, Adamowicz K, Katz A, et al. Assessment of quality of life in advanced non-small-cell lung cancer: an overview of recent randomized trials [ J ]. Cancer Treat Rev, 2012, 38 (6) : 807-814. 被引量:1
-
7Soussan M, Chouahnia K, Maisonobe JA, et al. Prognostic implications of volume-based measurements on FDG PET/CT in stage m non- small-cell lung cancer after induction chemotherapy [ J ]. Eur J Nucl Med Mol Imaging, 2013, 40(5) : 6684576. 被引量:1
-
8Skoura E, Datseris IE, Platis I, et al. Role of positron emission tomography in the early prediction of response to chemotherapy in patients with non-small-cell lung cancer [ J]. Clin Lung Cancer, 2012, 13(3) :181-187. 被引量:1
-
9Dahele M, Freeman M, Pearson S, et al. Early metabolic response evaluation after stereotactic radiotherapy for lung cancer: pilot experience with 18 F-fluorodeoxyglucose positron emission tomography-computed tomography [ J ]. Clin Oncol (R Coll Radiol), 2011, 23(5): 359-363. 被引量:1
-
10Saga T, Koizumi M, Inubushi M, et al. PET/CT with 3'-deoxy- 3' -[ 18F] fluorothymidine for lung cancer patients receiving carbon- ion radiotherapy[ J ]. Nucl Med Commun, 2011, 32 (5) : 348-355. 被引量:1
二级参考文献34
-
1Molina JR,Adjei AA,Jett JR.Advances in chemotherapy of non-small cell lung cancer[J].Chest,2006,130 (4):1211. 被引量:1
-
2Fehm T,Sagalowsky A,Clifford E,et al.Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant[J].Clin Cancer Res,2002,8 (7):2073. 被引量:1
-
3Pretlow TG,Schwartz S,Giaconia JM,et al.Prostate cancer and other xenografts from cells in peripheral blood of patients[J].Cancer Res,2000,60 (15):4033. 被引量:1
-
4Muller P,Schlimok G.Bone marrow micrometastases of epithelial tumors:Detection and clinical relevance[J].J Cancer Res Clin Oncol,2000,126 (11):607. 被引量:1
-
5Ge M J,Shi D,Wu QC,et al.Observation of circulating turnout cells in patients with non-small cell lung cancer by real-time fluorescent quantitative reverse transcriptase-polymerase chain reaction in peroperative period[J].J Cancer Res Clin Oncol,2006,(4):248. 被引量:1
-
6Passlick B,Kubuschok B,Izbicki JR,et al.Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer[J].Ann Thorac Surg,1999,68 (6):2053. 被引量:1
-
7Yasumoto K,Osaki T,Watanabe Y,et al.Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected nonsmall cell lung cancer:A multicenter prospective study[J].Ann Thorac Surg,2003,76 (1):194. 被引量:1
-
8Ring AE,Zabaglo L,Ormaerod MG,et al.Detection of circulating epitherlial cells in the blood of patients with breast cancer:Comparison of three techniques[J].Br J Cancer,2005,92 (5):906. 被引量:1
-
9Brandt B,Junker R,Griwatz C,et al.Isolation of prostatederived single cells and cell clusters from human peripheral blood[J].Cance Res,1996,56 (20):4556. 被引量:1
-
10Benez A,Geiselhart A,Handqretinqer R,et al.Detection of circulating melanoma cells by immunomagnetic cell sorting[J].J Clin Lab Anal,1999,13 (5):229. 被引量:1
共引文献65
-
1李晶,姜北,万鹏,李娜,王于理,巩平.晚期非小细胞肺癌患者循环肿瘤细胞检测的临床意义[J].中国全科医学,2013,16(27):3202-3204. 被引量:14
-
2孙永昌.慢性阻塞性肺疾病与肺癌的相关性[J].中华肺部疾病杂志(电子版),2012,5(4):5-7. 被引量:6
-
3刘明强,洪志鹏.肺肿瘤手术治疗的现状与未来[J].中华肺部疾病杂志(电子版),2013,6(1):53-55. 被引量:7
-
4钱频,钱桂生.老年人慢性阻塞性肺疾病的诊断与治疗[J].中华肺部疾病杂志(电子版),2013,6(2):4-6. 被引量:14
-
5冯飞,田辉,岳韦名,李林,李树海,高存,司立博,鲁铭.EGR-1蛋白在人肺鳞状细胞癌组织中的表达及其临床意义[J].中国肿瘤生物治疗杂志,2013,20(4):456-460.
-
6蔡欣,胡冬梅,高雪,高鹤立,孙志刚,吴泰华.非小细胞肺癌中自分泌运动因子受体的过表达及对患者预后的影响[J].中华肺部疾病杂志(电子版),2013,6(4):17-20. 被引量:3
-
7穆峰,曾健滢,陈继冰,姚飞,刘卫群,李家亮,牛立志,左建生,徐克成.经皮全面冷冻治疗Ⅳ期肺癌生存分析[J].中华肺部疾病杂志(电子版),2013,6(4):21-24. 被引量:2
-
8陈勃江,陈红,李为民.核糖体蛋白S6在肿瘤中作用的研究进展[J].中华肺部疾病杂志(电子版),2013,6(4):56-59. 被引量:4
-
9张瑞婕,郑世珍,戢福云.肺癌与线粒体DNA遗传变异[J].中华肺部疾病杂志(电子版),2013,6(5):64-67. 被引量:2
-
10任程,陈虹.支气管肺癌的介入治疗[J].中华肺部疾病杂志(电子版),2013,6(5):68-70. 被引量:2
同被引文献42
-
1Jemal A, Bray F, Center MM, et al. Global cancer statistics [ J ]. CA Cancer J Clin, 2011, 61(2) : 69-90. 被引量:1
-
2Tyldesley S, Boyd C, Schulze K, et al. Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach [J]. Int J Radiat Oncol Biol Phys, 2001, 49(4) : 973- 985. 被引量:1
-
3Socha J, Kolodziejczyk M, Kpka L. Outcome after PET-CT based radiotherapy for non-small cell lung cancer [ J]. Pneumonol Alergol Pol, 2013, 81(1): 30-39. 被引量:1
-
4Osti MF, Agolli L, Valeriani M, et al. Image guided hypofractionated 3-dimensianal radiation therapy in patients with inoperable advanced stage non-small cell lung cancer [ J]. Int J Radiat Oncol Biol Phys, 2013, 85(3) : e157-163. 被引量:1
-
5Kioi M, Vogel H, Schultz G, et al. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice [J]. J CIin Invest, 2010, 120(3) : 694-705. 被引量:1
-
6Ahn GO, Brown JM. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis : role of bone marrow-derived myelomonocytic ceils [J]. Cancer Cell, 2008, 13(3) : 193-205. 被引量:1
-
7Chen FI-I, Chiang C,S, Wang CC, et al. Radiotherapy decreases vascular density and causes hypoxia with maerophage aggregation in TRAMP- C1 prostate tumors [ J]. Clin Cancer Res, 2009, 15 (5) : 1721- 1729. 被引量:1
-
8Priceman SJ, Sung JL, Shaposhnik Z, et al. Targeting distinct tumor- infiltrating myeloid cells by inhibiting CSF-1 receptor: combatingtumor evasion of antiangiogenic therapy [J]. Blood, 2010, 115 (7) : 1461-1471. 被引量:1
-
9Tang DG, Conti CJ. Endothelial cell development, vasculogenesis, angiogenesis, and tumor neovascularization : an update [ J ]. Semin Thromb Hemost, 2004, 30( 1 ) : 109-117. 被引量:1
-
10Stephens TC, Currie GA, Peacock JH. Repopulation of gamma- irradiated Lewis lung carcinoma by malignant ceils and host macrophage progenitors [ J ]. Br J Cancer, 1978, 38 (5) : 573- 582. 被引量:1
引证文献6
-
1徐燕梅,崔天祥,张晓晶,李德志,孙建国.外周血单核细胞数量与肺癌放疗近、远期疗效的相关性分析[J].中华肺部疾病杂志(电子版),2014,7(2):29-33. 被引量:7
-
2李玉.肺癌放疗患者CT灌注值变化及其在预后评估中的作用[J].临床肺科杂志,2015,20(1):113-115. 被引量:2
-
3罗萌,徐瑜,胡义德.EGFR基因21外显子L858R突变肺腺癌患者化疗和靶向治疗疗效的回顾性分析[J].中华肺部疾病杂志(电子版),2017,10(1):20-24. 被引量:4
-
4曾卫珊,胡元明,梁翠珊.CT在原发性肺淋巴上皮瘤样癌诊断及疗效评估中的价值[J].临床放射学杂志,2018,37(4):623-626. 被引量:4
-
5熊宗恒,马红兵,党明,刘志刚,奚颖,石宗林,王超,杨洋,杨得振.两种方法治疗EGFR19del阳性肺腺癌患者的疗效和生存期比较[J].检验医学与临床,2020,17(3):386-388.
-
6刘治辉,张国政.124例肺癌患者放化疗后致肺部感染的病原菌分布及其耐药性分析[J].抗感染药学,2021,18(8):1122-1126. 被引量:7
二级引证文献24
-
1苏端玉,林志安,秦文娟,郭群煌,郝兰香.肺癌患者放化疗后肺部感染病原菌及其耐药性分析[J].中国微生态学杂志,2022,34(12):1408-1411. 被引量:6
-
2徐燕梅,崔天祥,张晓晶,李德志,孙建国.外周血单核细胞数量与肺癌放疗近、远期疗效的相关性分析[J].中华肺部疾病杂志(电子版),2014,7(2):29-33. 被引量:7
-
3樊涛,韩琴芳,郭利锋.肺癌灌注成像参数与患者生存期的关系[J].现代肿瘤医学,2015,23(19):2844-2846.
-
4牛真珍,伊吉普,袁松波,张碧娇.单核细胞VCS参数在肿瘤患者放化疗前后的变化及意义[J].中国卫生检验杂志,2016,26(16):2341-2342. 被引量:1
-
5顾晓雯,崔磊,江建芹,蔡荣芳.CT灌注成像评估肺癌疗效的研究进展[J].中华放射学杂志,2016,50(10):804-806. 被引量:23
-
6罗蒙,孙勤国.单核细胞及中性粒细胞/淋巴细胞比值与中晚期肿瘤的相关性[J].中国医药导报,2017,14(32):92-96. 被引量:6
-
7王婷,马惠文,王东林,李代蓉,余慧青,王思雄,王恩文.EGFR基因21外显子L858R突变肺腺癌患者化疗和靶向治疗疗效的对比研究[J].现代生物医学进展,2018,18(2):348-351.
-
8王春英,程明,汪德文,于正荣,闻应时,陈丽萍.晚期肺腺癌患者EGFR-TKI治疗耐药后治疗策略临床研究[J].系统医学,2017,2(20):122-125. 被引量:3
-
9侯平,张俊榕.应用术前外周血NLR,dNLR,PLR及LMR预测梗阻性左半结肠癌患者预后[J].福建医科大学学报,2018,52(6):389-395. 被引量:9
-
10董志成,陈谦,胡春霞,姜维美,李晓敏.EGFR-TKI靶向联合化疗治疗晚期肺腺癌的临床研究[J].中外医学研究,2019,17(24):52-54. 被引量:3
-
1李桦,王荣玲,吴俊波.肺癌局部热疗联合放化疗61例分析[J].中国误诊学杂志,2009,9(4):919-920.
-
2王继生,黄雪梅.放化疗治疗非小细胞肺癌65例分析[J].大同医学专科学校学报,2001,21(4):3-4.
-
3温丽娟,张晴,牛洪欣,吴玉芬.甘氨双唑钠对非小细胞肺癌放化疗的增敏作用及安全性[J].山东医药,2016,56(9):37-39. 被引量:6
-
4李彪.^(18)F-脱氧葡萄糖PET及PET-CT监测非小细胞肺癌放化疗疗效的价值[J].诊断学理论与实践,2010,9(2):129-132. 被引量:2
-
5徐碧琳,赖繁彩.护理干预对肺癌放化疗患者生活质量的影响[J].中国伤残医学,2014,22(24):171-172. 被引量:1
-
6梅铭惠.生物治疗在肝细胞癌中的应用[J].腹部外科,2005,18(2):89-91.
-
7潘锦瑶,杨齐华.高强度聚焦超声与中西医结合治疗肝脏肿瘤[J].现代消化及介入诊疗,2005,10(3):172-174.
-
8冷传春,梅家转.吉西他滨联合顺铂治疗耐药的转移性乳腺癌的临床观察[J].临床肿瘤学杂志,2007,12(3):216-217. 被引量:3
-
9黄海,刘胜利.肝门部胆管癌外科治疗进展[J].医师进修杂志(外科版),2004,27(12):1-4.
-
10谭今,张波,陈志新,陈佳平.正电子发射断层显像在胃癌的应用[J].华西医学,2006,21(2):402-403.